Joseph I Shapiro

USPTO Granted Patents = 18 (Patent Applications = 9)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 52(Granted Patents)

Location History:

Toledo, OH (US) (2006 - 2017)
Huntington, WV (US) (2021 - 2024)

Company Filing History:

9 out of 361

The University of Toledo

patents

5 out of 30

Marshall University Research Corporation

patents

3 out of 44

Medical College of Ohio

patents

4. 1 out of 832,912

Other

patents

Years Active: 2006-2024

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11958915 - Methods for treatment and diagnosis of non-alcoholic steatohepatitis and/or hepatocellular carcinoma (2024-04-16),

2. 11865162 - Compositions and methods for treatment of uremic cardiomyopathy (2024-01-09),

3. 11311600 - Methods for treating obesity (2022-04-26),

4. 11220528 - Compositions and methods for treating pulmonary hypertension (2022-01-11),

5. 10973867 - Compositions and methods for treating retinopathy (2021-04-13),

6. 9663561 - Methods of treatment of cancer using SRC-modulating peptides (2017-05-30),

7. 9492463 - Na/K-ATPase ligand and uses thereof in wound healing (2016-11-15),

8. 9226952 - Na/K-ATPase-derived peptide Src inhibitors and ouabain antagonists and uses thereof (2016-01-05),

9. 9114126 - Na/K-ATPase ligands, ouabain antagonists, assays and uses thereof (2015-08-25),

10. 9072751 - Na/K-ATPase ligand (2015-07-07),

11. 8981051 - Na+/K+-ATPase-specific peptide inhibitors/activators of Src and Src family kinases (2015-03-17),

12. 8906891 - Na/K-ATPase ligand (2014-12-09),

13. 8283441 - Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases (2012-10-09),

14. 7884068 - Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use (2011-02-08),

15. 7605130 - Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction (2009-10-20),

Title: Innovations and Contributions of Joseph I Shapiro

Introduction

Joseph I Shapiro is a prominent inventor based in Toledo, OH, known for his significant contributions to medical science. With a total of 18 patents to his name, he has made remarkable advancements in the treatment and diagnosis of various health conditions, particularly those related to liver diseases and cardiomyopathy.

Latest Patents

Among his latest patents, Shapiro has developed methods for the treatment and diagnosis of non-alcoholic steatohepatitis and hepatocellular carcinoma. These methods involve administering a polypeptide antagonist of a Na/K ATPase/Src receptor complex to patients in need. Additionally, he has created assays for diagnosing or prognosing these conditions by analyzing biomarkers such as Caveolin-1, Survivin, and SMAC in biological samples. Another notable patent focuses on the treatment of uremic cardiomyopathy, which also utilizes a polypeptide antagonist and includes methods for treating anemia associated with chronic kidney disease.

Career Highlights

Shapiro has had a distinguished career, working with esteemed institutions such as the University of Toledo and Marshall University Research Corporation. His work has not only advanced scientific understanding but has also paved the way for new therapeutic approaches in medicine.

Collaborations

Throughout his career, Shapiro has collaborated with notable colleagues, including Zijian Xie and Zi-Jian Xie, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Joseph I Shapiro's innovative work in medical treatments and diagnostics exemplifies the impact of dedicated inventors in advancing healthcare. His contributions continue to influence the medical community and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.